Medicine and Dentistry
Prostate Cancer
100%
Robot-Assisted Prostatectomy
87%
Partial Nephrectomy
85%
Neoplasm
65%
Cystectomy
56%
Continence
54%
Overall Survival
46%
Retrospective Study
42%
Retroperitoneal Lymph Node Dissection
33%
Clear Cell Renal Cell Carcinoma
31%
Castration Resistant Prostate Cancer
31%
Urinary System
30%
Recurrence Free Survival
28%
Transitional Cell Carcinoma
28%
Neoadjuvant Chemotherapy
28%
Prostate Specific Antigen
28%
Multivariate Analysis
26%
Disease
26%
Surgical Margin
24%
Bleeding
24%
Recurrent Disease
23%
Cancer Specific Survival
22%
Urine Incontinence
21%
Magnetic Resonance Imaging
18%
Progression Free Survival
18%
Androgen Receptor
18%
Bladder Cancer
17%
Prostate Adenocarcinoma
17%
Propensity Score Matching
17%
Glomerular Filtration Rate
16%
Adverse Event
16%
Prognostic Factor
15%
Urinary Diversion
15%
Postoperative Ileus
15%
Biochemical Recurrence
15%
Ischemia
15%
Biological Marker
15%
Kidney Tumour
15%
Nephroureterectomy
15%
Operation Duration
15%
Urine Cytology
15%
Kidney Metastasis
14%
Pembrolizumab
14%
Brachytherapy
14%
Long Term Survival
14%
Extracorporeal
14%
Iodine 125
14%
Combination Therapy
14%
Ileal Conduit
14%
Radical Nephrectomy
14%
Liposarcoma
14%
Olaparib
14%
Fournier Gangrene
14%
Ureter
14%
Bladder Metastasis
14%
Procollagen
14%
Corynebacterium urealyticum
14%
Surgeon
14%
Bronchogenic Cyst
14%
Bone Metastasis
14%
Alkaline Phosphatase
14%
Inferior Vena Cava
14%
Disease Exacerbation
14%
Molecularly Targeted Therapy
14%
Cabazitaxel
14%
P16
14%
Muscle Invasive Bladder Cancer
14%
Thrombectomy
14%
Dentigerous Cyst
14%
Ligation
14%
Spermatic Cord
14%
Computer Assisted Tomography
14%
Oncology
14%
Immunoglobulin
14%
Inguinal Orchiectomy
14%
Acid Phosphatase Prostate Isoenzyme
11%
Docetaxel
10%
Ileus
10%
Predictive Factor
10%
Diagnosis
8%
Geriatrics
8%
Bone Scintigraphy
8%
Targeted Therapy
8%
Clinical Trial
7%
Patient Counseling
7%
Columnar Epithelium
7%
Lenabasum
7%
Gleason Score
6%
Pelvis
6%
Prostatectomy
6%
Lymphovascular Invasion
6%
Surgical Technique
6%
Tyrosine-Kinase Inhibitor
6%
Hazard Ratio
6%
Proportional Hazards Model
6%
Shared Decision Making
5%
Colposuspension
5%
Blood Transfusion
5%
Cancer Control
5%
Pelvis Cancer
5%
Keyphrases
Prostate Cancer
30%
Robot-assisted Radical Prostatectomy
28%
Pentafecta Outcomes
28%
Nerve Sparing
20%
High-grade Urothelial Carcinoma
14%
Partial Nephrectomy
14%
Poor Prognosis
14%
Prospective multi-institutional Study
14%
Renal Hilar Tumor
14%
Bladder Metastasis
14%
C-X-C Chemokine Receptor Type 4 (CXCR4)
14%
Deep Ensemble
14%
Robot-assisted Radical Nephrectomy
14%
Prostate-specific Antigen Response
14%
Ensemble Machine Learning
14%
Inferior Vena Cava Thrombectomy
14%
Testicular Epidermoid Cyst
14%
Alkaline Phosphatase
14%
Type I Procollagen
14%
Urethral Suspension
14%
Selective Clamping
14%
Regulatory T Cells
14%
Spermatic Cord
14%
Computed Tomography
14%
Premature Termination Codon
14%
Bladder Eversion
14%
Real-world Application
14%
Infiltration
14%
High-grade Prostate Cancer
14%
Secondary Bladder Cancer
14%
Liposarcoma
14%
Voided Urine Cytology
14%
Nuclear Area
14%
Efficacy Comparison
14%
Cancer Tissue
14%
Fournier's Gangrene
14%
Encrusted Pyelitis
14%
Abdominal MRI
14%
Corynebacterium Urealyticum
14%
Pseudostratified
14%
Bronchogenic Cyst
14%
Columnar Epithelium
14%
Disease Impact
14%
Retroperitoneal Mass
14%
Retroperitoneal Bronchogenic Cyst
14%
Carboxyl Terminus
14%
Abdominal US
14%
Intracorporeal Ileal Conduit
14%
Bone Metastasis
14%
Beyond Progression
14%
Stripping Technique
14%
Resistance to Immunotherapy
14%
Intraoperative Navigation
14%
High Complexity
14%
Laparoscopic Retroperitoneal Lymph Node Dissection
14%
Nomogram
14%
Propeptide
14%
Prostate Cancer Outcomes
14%
Outcome Patterns
14%
Prognostic Stratification
14%
125I Seed Implantation
14%
Alanine-serine-cysteine Transporter
14%
Immuno-oncology
14%
AR-V7
14%
Androgen Receptor Splice Variant
14%
Treg
13%
Hormonal Agents
12%
Prostate-specific Antigen
11%
Prostatic Acid Phosphatase
11%
Bladder Neck Reconstruction
10%
Primary Resistance
9%
Prostate-specific Antigen Failure
9%
Inguinal Orchiectomy
9%
Geriatric 8
8%
Bone Scan
8%
Retroperitoneal Lymph Node Dissection (RPLND)
7%
Teratoma with Malignant Transformation
7%
Testicular Mass
7%
Continence Recovery
7%
Biologically Effective Dose
7%
Rectus Fascia
7%
Cystopexy
7%
22Rv1
7%
Burch Colposuspension
7%
Simple Machine
6%
Primary Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Castration Resistant Prostate Cancer
71%
Prostate Cancer
59%
Androgen Receptor
59%
Overall Survival
54%
Renal Cell Carcinoma
42%
Kidney Metastasis
39%
Neoplasm
28%
Cabazitaxel
28%
Prostate Specific Antigen
26%
Docetaxel
24%
Progression Free Survival
22%
Immune Checkpoint Inhibitor
20%
Biological Marker
19%
Disease
18%
Malignant Neoplasm
18%
Adverse Event
18%
Immunotherapy
17%
Disease Exacerbation
16%
Combination Therapy
14%
Pembrolizumab
14%
Chemotherapy
14%
Bladder Cancer
14%
Recurrence Risk
14%
Heat Shock Protein 27
14%
Racemase
14%
Biochemical Recurrence
14%
Brain Disease
14%
Tryptophan 2,3 Dioxygenase
14%
Metastatic Colorectal Cancer
14%
Muscle Invasive Bladder Cancer
14%
Olaparib
14%
Immunoglobulin
14%
Acid Phosphatase Prostate Isoenzyme
11%
Indoleamine 2,3 Dioxygenase
10%
Branched Chain Amino Acid
9%
Recurrent Disease
9%
Protein Tyrosine Kinase Inhibitor
7%
Survival Prediction
6%
Kynurenine
6%
Enzalutamide
6%
Cancer Specific Survival
5%
Recurrence Free Survival
5%